• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec29
Controlling Shareholder of Chiome Pharmaceutical Plans to Reduce Shares
09:38
Dec1
Multiple Executives of ZhaoYan New Drug Completed their Stock Sale Plans
10:14
Nov27
Director Sun Yunxia of Zhaoyan New Drug Reduces 100,000 Shares
12:03
Nov14
Directors of Zhaoyan New Drug Reduced Shares
12:03
Nov13
Huaxi Securities Maintains '增持' Rating for Zhaoyan Pharmaceutical, Predicts Future Demand Improvement
06:44
Nov4
Executives of Syneos Health China Cut Shares Held
12:04

Schedules & Filings

Schedules
Filings
Oct30
Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 316.39 M, Net Income 19.77 M, EPS 0.0291

Aug26
Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 381.24 M, Net Income 19.81 M, EPS 0.0282

Aug14
Distribution Plan(CST)

Cash dividend 0.03 CNY

View More

Stock List

Top Gainers
Top Decliners
Northbound Connect
Symbol
Price
%Chg
Change
View More